DeepEyeVision is a prominent player in the health care industry, founded in 2016. The company focuses on innovating image diagnosis AI for ophthalmology, offering advanced remote image reading services, and comprehensive medical device programs.
With a strong emphasis on leveraging artificial intelligence to support ophthalmology practitioners, DeepEyeVision has garnered attention from investors. Its most recent milestone was the Seed Round investment in February 2020, with contributions from Deepcore and INDEE Japan.
This strategic investment not only showcases confidence from established players in the industry but also reinforces the company's potential for growth and innovation in the health care technology sector.